The impact of frailty on short-term mortality following primary total hip and knee arthroplasty due to osteoarthritis.


Journal

Age and ageing
ISSN: 1468-2834
Titre abrégé: Age Ageing
Pays: England
ID NLM: 0375655

Informations de publication

Date de publication:
01 06 2022
Historique:
received: 22 11 2021
entrez: 9 6 2022
pubmed: 10 6 2022
medline: 14 6 2022
Statut: ppublish

Résumé

We determined the association between frailty and short-term mortality following total hip and knee arthroplasty (THA/TKA) for osteoarthritis and also the impact of THA/TKA on short-term mortality compared with a control population. Frailty was assessed using a frailty index (categorised: fit, mild, moderate, severe frailty). The association between frailty and short-term mortality following THA/TKA was assessed using Cox regression. Mortality following THA/TKA was also compared with a control population with osteoarthritis but no previous THA/TKA, matched on year of birth, sex and quintile of index of multiple deprivation. A total of 103,563 cases who had a THA, 125,367 who had a TKA and matched controls contributed. Among those who had surgery, mortality increased with increasing frailty; adjusted hazard ratio (HR) (95% CI) at 30 days in severely frail versus fit: following THA, 2.85 (1.84, 4.39) and following TKA, 2.14 (1.29, 3.53). The predicted probability of 30-day mortality following THA/TKA varied by age, sex and frailty: following THA, from 0.05% among fit women aged 60-64 years to 6.55% among men with severe frailty aged ≥90 years. All-cause 30-day mortality was increased in fit cases following THA and TKA, respectively, versus fit controls (adjusted HR (95% CI), 1.60 (1.15, 2.21) and 2.98 (1.81, 4.89)), though not among cases with mild, moderate or severe frailty versus controls in the same frailty category. Short-term mortality increased with increasing frailty following THA/TKA. Comparison of mortality among cases and controls may be affected by a 'healthy surgery' selection effect.

Sections du résumé

BACKGROUND
We determined the association between frailty and short-term mortality following total hip and knee arthroplasty (THA/TKA) for osteoarthritis and also the impact of THA/TKA on short-term mortality compared with a control population.
METHODS
Frailty was assessed using a frailty index (categorised: fit, mild, moderate, severe frailty). The association between frailty and short-term mortality following THA/TKA was assessed using Cox regression. Mortality following THA/TKA was also compared with a control population with osteoarthritis but no previous THA/TKA, matched on year of birth, sex and quintile of index of multiple deprivation.
RESULTS
A total of 103,563 cases who had a THA, 125,367 who had a TKA and matched controls contributed. Among those who had surgery, mortality increased with increasing frailty; adjusted hazard ratio (HR) (95% CI) at 30 days in severely frail versus fit: following THA, 2.85 (1.84, 4.39) and following TKA, 2.14 (1.29, 3.53). The predicted probability of 30-day mortality following THA/TKA varied by age, sex and frailty: following THA, from 0.05% among fit women aged 60-64 years to 6.55% among men with severe frailty aged ≥90 years. All-cause 30-day mortality was increased in fit cases following THA and TKA, respectively, versus fit controls (adjusted HR (95% CI), 1.60 (1.15, 2.21) and 2.98 (1.81, 4.89)), though not among cases with mild, moderate or severe frailty versus controls in the same frailty category.
CONCLUSION
Short-term mortality increased with increasing frailty following THA/TKA. Comparison of mortality among cases and controls may be affected by a 'healthy surgery' selection effect.

Identifiants

pubmed: 35679192
pii: 6604740
doi: 10.1093/ageing/afac118
pmc: PMC9180921
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Versus Arthritis
ID : 21755
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the British Geriatrics Society. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Références

J Arthroplasty. 2020 Sep;35(9):2488-2494
pubmed: 32444236
Age Ageing. 2019 Jan 1;48(1):152-156
pubmed: 30321256
Ther Adv Musculoskelet Dis. 2020 Dec 25;12:1759720X20981219
pubmed: 33488786
Int J Epidemiol. 2015 Jun;44(3):827-36
pubmed: 26050254
J Arthroplasty. 2016 Nov;31(11):2389-2394
pubmed: 27240960
Age Ageing. 2019 Nov 1;48(6):922-926
pubmed: 31566668
J Arthroplasty. 2019 Jan;34(1):140-144
pubmed: 30337252
Lancet. 2019 Oct 12;394(10206):1365-1375
pubmed: 31609228
Age Ageing. 2016 May;45(3):353-60
pubmed: 26944937
Int J Epidemiol. 2017 Aug 1;46(4):1093-1093i
pubmed: 28338941
J Arthroplasty. 2017 Sep;32(9S):S177-S182
pubmed: 28442185
J Arthroplasty. 2020 Oct;35(10):2878-2885
pubmed: 32576431
Lancet. 2013 Sep 28;382(9898):1097-104
pubmed: 24075049
J Arthroplasty. 2017 Oct;32(10):2963-2968
pubmed: 28559198
Eur J Epidemiol. 2019 Jan;34(1):91-99
pubmed: 30219957
J Arthroplasty. 2019 Jan;34(1):56-64.e5
pubmed: 30340916
Lancet. 2014 Oct 18;384(9952):1429-36
pubmed: 25012118
BMC Geriatr. 2008 Sep 30;8:24
pubmed: 18826625
Int J Epidemiol. 2019 Dec 1;48(6):1740-1740g
pubmed: 30859197

Auteurs

Michael J Cook (MJ)

Centre for Epidemiology Versus Arthritis, Division of Musculoskeletal and Dermatological Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester, UK.

Mark Lunt (M)

Centre for Epidemiology Versus Arthritis, Division of Musculoskeletal and Dermatological Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester, UK.

Timothy Board (T)

Department of Trauma and Orthopaedic Surgery, Wrightington Hospital, Wigan, UK.

Terence W O'Neill (TW)

Centre for Epidemiology Versus Arthritis, Division of Musculoskeletal and Dermatological Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester, UK.
NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH